April, 2017 – AACR

Posted on April 25, 2017April 26, 2017 by IGM

Multimeric Anti-DR5 IgM antibody displays potent cytotoxicity in vitro and promotes tumor regression in vivo.
Continue reading→

Posted on April 25, 2016April 26, 2017 by IGM

High Avidity Anti-CD20 IgM Antibody for Enhanced Complement-Dependent Cell Killing of Low CD20 Expressing Tumor Cells.

Posted on April 25, 2014April 26, 2017 by IGM

IGM-55.5, a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma.